Pritha Dasgupta

723 total citations
28 papers, 566 citations indexed

About

Pritha Dasgupta is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pritha Dasgupta has authored 28 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 15 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pritha Dasgupta's work include Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (9 papers). Pritha Dasgupta is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (9 papers). Pritha Dasgupta collaborates with scholars based in United States, India and Japan. Pritha Dasgupta's co-authors include Yuichiro Tanaka, Marisa Shiina, Rajvir Dahiya, Yutaka Hashimoto, Soichiro Yamamura, Priyanka Kulkarni, Shahana Majid, Varahram Shahryari, Sharanjot Saini and Guoren Deng and has published in prestigious journals such as PLoS ONE, Cancer Research and Fertility and Sterility.

In The Last Decade

Pritha Dasgupta

27 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pritha Dasgupta United States 13 378 311 104 63 31 28 566
Lorand Magdo Romania 9 582 1.5× 408 1.3× 81 0.8× 64 1.0× 20 0.6× 13 759
Amine Belaïd France 13 510 1.3× 243 0.8× 91 0.9× 68 1.1× 30 1.0× 22 821
Mariana Bisarro dos Reis Brazil 14 280 0.7× 154 0.5× 65 0.6× 116 1.8× 9 0.3× 35 502
Fengmei Cui China 15 275 0.7× 154 0.5× 118 1.1× 80 1.3× 13 0.4× 49 551
Tengxiang Chen China 12 294 0.8× 181 0.6× 76 0.7× 70 1.1× 9 0.3× 48 516
Fei Pang China 14 231 0.6× 147 0.5× 75 0.7× 76 1.2× 52 1.7× 42 512
Jiajia Wang China 15 567 1.5× 466 1.5× 37 0.4× 48 0.8× 14 0.5× 35 780
Xiuling Li China 14 228 0.6× 145 0.5× 82 0.8× 108 1.7× 16 0.5× 29 468
Xueying Yang China 15 474 1.3× 254 0.8× 54 0.5× 124 2.0× 10 0.3× 36 714
Hao Gu China 13 464 1.2× 313 1.0× 43 0.4× 69 1.1× 23 0.7× 35 638

Countries citing papers authored by Pritha Dasgupta

Since Specialization
Citations

This map shows the geographic impact of Pritha Dasgupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pritha Dasgupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pritha Dasgupta more than expected).

Fields of papers citing papers by Pritha Dasgupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pritha Dasgupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pritha Dasgupta. The network helps show where Pritha Dasgupta may publish in the future.

Co-authorship network of co-authors of Pritha Dasgupta

This figure shows the co-authorship network connecting the top 25 collaborators of Pritha Dasgupta. A scholar is included among the top collaborators of Pritha Dasgupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pritha Dasgupta. Pritha Dasgupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulkarni, Priyanka, Pritha Dasgupta, Yutaka Hashimoto, et al.. (2021). A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis. Cancer Research. 81(6). 1500–1512. 42 indexed citations
2.
Shiina, Marisa, Yutaka Hashimoto, Priyanka Kulkarni, et al.. (2021). Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans. BMC Cancer. 21(1). 1028–1028. 8 indexed citations
3.
Hashimoto, Yutaka, Marisa Shiina, Shigekatsu Maekawa, et al.. (2021). Suppressor effect of catechol-O-methyltransferase gene in prostate cancer. PLoS ONE. 16(9). e0253877–e0253877. 6 indexed citations
4.
Kulkarni, Priyanka, Pritha Dasgupta, Nadeem S. Bhat, et al.. (2020). Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells. Toxicology and Applied Pharmacology. 409. 115308–115308. 21 indexed citations
5.
Dasgupta, Pritha, Priyanka Kulkarni, Nadeem S. Bhat, et al.. (2020). Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer. Toxicology and Applied Pharmacology. 401. 115102–115102. 26 indexed citations
6.
Dasgupta, Pritha, Priyanka Kulkarni, Shahana Majid, et al.. (2020). LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Cell Death and Disease. 11(8). 660–660. 47 indexed citations
7.
Hashimoto, Yutaka, Marisa Shiina, Pritha Dasgupta, et al.. (2019). Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer. Cancer Prevention Research. 12(9). 585–598. 22 indexed citations
8.
Dasgupta, Pritha, Priyanka Kulkarni, Nadeem S. Bhat, et al.. (2019). Abstract 4659: Cadmium induced malignant transformation involves activation of the Erk/MAPK pathway. Cancer Research. 79(13_Supplement). 4659–4659. 1 indexed citations
9.
Dasgupta, Pritha, Priyanka Kulkarni, Shahana Majid, et al.. (2018). MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 17(5). 1061–1069. 82 indexed citations
10.
Kulkarni, Priyanka, Pritha Dasgupta, Nadeem S. Bhat, et al.. (2018). Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Molecular Cancer Research. 16(11). 1750–1760. 44 indexed citations
11.
Bhat, Nadeem S., Altaf A. Dar, Sharanjot Saini, et al.. (2018). Abstract 4292: Negative regulation of oncogenes by a novel tumor suppressor microRNA in prostate cancer. Cancer Research. 78(13_Supplement). 4292–4292. 5 indexed citations
12.
Kato, Taku, Yutaka Hashimoto, Shigekatsu Maekawa, et al.. (2017). Abstract 2288: Effects of tobacco smoking and alcohol consumption on risks of CYP1B1 polymorphisms for prostate cancer. Cancer Research. 77(13_Supplement). 2288–2288.
13.
Imai-Sumida, Mitsuho, Takeshi Chiyomaru, Shahana Majid, et al.. (2017). Abstract 199: Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Cancer Research. 77(13_Supplement). 199–199. 1 indexed citations
14.
Yang, Thao Ly, Divya Bhagirath, Kirandeep Sekhon, et al.. (2017). Abstract 4435: Exosomal miR-3622a as prognostic marker in prostate cancer. Cancer Research. 77(13_Supplement). 4435–4435. 1 indexed citations
15.
Dasgupta, Pritha, et al.. (2015). Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937. Nutrition. 31(7-8). 1031–1037. 12 indexed citations
17.
Dasgupta, Pritha, et al.. (2013). Role of Di-allyl Disulfide, a Garlic Component in NF-κB Mediated Transient G2-M Phase Arrest and Apoptosis in Human Leukemic Cell-lines. Nutrition and Cancer. 65(4). 611–622. 20 indexed citations
18.
Saha, Siddhartha, et al.. (2012). Synergistic effect of conjugated linolenic acid isomers against induced oxidative stress, inflammation and erythrocyte membrane disintegrity in rat model. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(12). 1951–1970. 29 indexed citations
19.
20.
Dasgupta, Pritha & Joan Barber. (2004). Admission patterns of patients with personality disorder. Psychiatric Bulletin. 28(9). 321–323. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026